Biologics News

CTL Medical Corporation recently announced it has reached an agreement to acquire AccelSPINE.

Editor’s note: In this second part of the FORTE article by members of the Orthopaedics and Traumatology Department at Hacettepe University in Ankara, Turkey, they discuss principles of fracture healing and bone metabolism. Read part 1 of the article here and look for more articles from FORTE members in future issues of Orthopaedics Today Europe.

Meditech Spine LLC recently announced it has received FDA clearance for its Talos interbody devices to be used with allograft comprised of cancellous or corticocancellous bone graft.

Results of this study indicated an association between the use of testosterone therapy in patients with thrombophilia and an increased risk for osteonecrosis.

K2M Group Holdings Inc. recently announced it received 510(k) clearance from the FDA to market its CASCADIA Lateral Interbody System featuring the company’s proprietary Lamellar Titanium Technology.

Orthopedics Today features 8 videos that were among the most popular in 2015.

Orthopedics Today features 8 stories and videos that were among the most popular in 2015.

Results from a study cited longer hospital stays and more expensive hospitalizations in orthopedic patients who developed hyponatremia, with greater chances of development with older age, spine surgery, hip arthroplasty and amount of lactated Ringer solution used.

Medtronic announced the FDA approval of additional spine surgery indications for its Infuse Bone Graft. Upon receiving final labeling approval from the FDA, the company expects to begin marketing the expanded indications in early 2016.

Bioventus LLC recently announced it has acquired BioStructures LLC, a developer and marketer of bioresorbable bone graft products for spinal and orthopedic surgical applications. However, terms of the acquisition were not disclosed.